0 CHECKOUT

Argentina Pharmaceuticals and Healthcare Report Q2 2016

  • ID: 3625609
  • February 2016
  • Region: Argentina
  • 109 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Laboratorios Bago
  • Novartis
  • Sanofi
  • MORE

Over the next five years, Argentina's pharmaceutical and healthcare sector growth trends are expected to substantially benefit from the improving business environment, including the liberalisation of the country's external accounts. Moreover, Argentina's geographical proximity, strong drug production ability and a skilled workforce will provide excellent investment opportunities for foreign drugmakers to expand their presence in Latin America, including through local market leaders.

Despite Argentina's favourable long-term growth outlook, short-term economic turbulence will negatively impact on returns in the pharmaceutical and healthcare sector through the next few quarters, with higher investment returns to pick up over a multi-year horizon.

Headline Expenditure Projections

Pharmaceuticals: ARS64.02bn (USD6.96bn) in 2015 to ARS79.27bn (USD5.47bn) in 2016; +23.8% in local currency terms and -21.4% in US dollar terms. Forecast revised upwards in local currency terms and downwards in US dollar terms from last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Laboratorios Bago
  • Novartis
  • Sanofi
  • MORE

- Table: Headline Pharmaceutical and Healthcare Forecasts (2014-2020)

- SWOT

- Industry Forecast

- Pharmaceutical Market Forecast

- Table: Pharmaceutical Sales, Historical Data And Forecasts (Argentina 2012-2020)

- Healthcare Market Forecast

- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020)

- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020)

- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020)

- Prescription Drug Market Forecast

- Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020)

- Patented Drug Market Forecast

- Table: Patented Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020)

- Generic Drug Market Forecast

- Table: Generic Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020)

- OTC Medicines Forecast

- Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Argentina 2012-2020)

- Pharmaceutical Trade Forecast

- Table: Pharmaceutical Trade Data And Forecasts (Argentina 2014-2020)

- Table: Pharmaceutical Trade Data And Forecasts local currency (Argentina 2014-2020)

- Industry Risk Reward Index

- Americas Risk/Reward Index

- Argentina Risk/Reward Index

- Rewards

- Risks

- Regulatory Review

- Table: Product Registration, Annex I & II Listed Countries

- Intellectual Property Environment

- Pricing Regime

- Table: Pharmaceutical Price Build-Up

- Reimbursement Regime

- Market Overview

- Healthcare Sector

- Table: Healthcare Resources (Argentina 2010-2015)

- Table: Healthcare Personnel (Argentina 2010-2015)

- Table: Healthcare Activity (Argentina 2010-2015)

- Research & Development

- Clinical Trials

- Epidemiology

- Competitive Landscape

- Research Based Industry

- Table: Multinational Market Activity

- Generic Drugmakers

- Pharmaceutical Distribution

- Pharmaceutical Retail Sector

- Company Profile

- GlaxoSmithKline

- Laboratorios Bago

- Novartis

- Sanofi

- Demographic Forecast

- Table: Population Headline Indicators (Argentina 1990-2025)

- Table: Key Population Ratios (Argentina 1990-2025)

- Table: Urban/Rural Population & Life Expectancy (Argentina 1990-2025)

- Table: Population By Age Group (Argentina 1990-2025)

- Table: Population By Age Group % (Argentina 1990-2025)

- Glossary

- Methodology

- Pharmaceutical Expenditure Forecast Model

- Healthcare Expenditure Forecast Model

- Notes On Methodology

- Risk/Reward Index Methodology

- Index Overview

- Table: Pharmaceutical Risk/Reward Index Indicators

- Indicator Weightings 109

Note: Product cover images may vary from those shown
3 of 4

- GlaxoSmithKline
- Laboratorios Bago
- Novartis
- Sanofi

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.